Literature DB >> 30166214

miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1.

Xiuyan Wang1, Ming Qi2.   

Abstract

BACKGROUND: MicroRNAs bind the 3' untranslated regions (3'-UTRs) of mRNAs and thereby regulate gene expression post-transcriptionally and play an important role in cancer delvelopment. In the present study, we have explored the role of miR-718 in papillary thyroid cancer cell malignancy. MATERIALS/
METHODS: Here we examined the miRNA expression in human papillary thyroid cancer by RT-PCR. Luciferase activity, RT-PCR and western blot assays were used to confirmed the target of miRNA. MTT, colony formation, transwell, glucose consumption and lactate production assays were performed to analyze papillary thyroid cancer cell function. Western blot for signaling proteins was used to reveal the mechanism.
RESULTS: We first determined that miR-718 mRNA expression levels in PTC samples were reduced. The 3'-UTR of 3-Phosphoinositide Dependent Protein Kinase 1 (PDPK1) was then identified as a target of miR-718. Luciferase assays showed that miR-718 does in fact bind the wild-type PDPK1 3'-UTR. We assessed the effects of miR-718 on p-Akt, Akt, p-mTOR and mTOR expression. We determined that miR-718 negatively regulates their levels, respectively, of Akt-mTOR pathway components. We then assessed the effects of miR-718 on PTC cell behavior. The results revealed that miR-718 negatively regulates PTC cell proliferation, migration, and invasion. In addition, miR-718 was found to inhibit cell glucose metabolism, likely through the Akt-mTOR pathway. Finally, PDPK1 could rescue PTC cell inhibition induced by miR-718.
CONCLUSIONS: The present study strongly suggests that miR-718 inhibits PTC cell proliferation, metastasis, and glucose metabolism by negatively regulating the Akt-mTOR signaling pathway.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Akt-mTOR pathway; Malignancy; PDPK1; Papillary thyroid cancer; miR-718

Mesh:

Substances:

Year:  2018        PMID: 30166214     DOI: 10.1016/j.prp.2018.08.022

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation.

Authors:  Petr Celakovsky; Helena Kovarikova; Viktor Chrobok; Jan Mejzlik; Jan Laco; Hana Vosmikova; Marcela Chmelarova; Ales Ryska
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718.

Authors:  Zhenmin Ding; Pengcheng Ye; Xiaohu Yang; Hongmiao Cai
Journal:  Biosci Rep       Date:  2019-04-02       Impact factor: 3.840

3.  Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.

Authors:  Feng Guo; Qingfeng Fu; Yang Wang; Guoqing Sui
Journal:  J Cell Mol Med       Date:  2019-07-14       Impact factor: 5.310

Review 4.  Regulators of glucose uptake in thyroid cancer cell lines.

Authors:  Shabnam Heydarzadeh; Ali Asghar Moshtaghie; Maryam Daneshpoor; Mehdi Hedayati
Journal:  Cell Commun Signal       Date:  2020-06-03       Impact factor: 5.712

5.  A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells.

Authors:  Ayla Orang; Saira R Ali; Janni Petersen; Ross A McKinnon; Amanda L Aloia; Michael Z Michael
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.996

Review 6.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

7.  MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.

Authors:  Dong Cao; Shanshan Ge; Mengchun Li
Journal:  J Bone Oncol       Date:  2022-01-19       Impact factor: 4.072

8.  A Next-Generation Sequencing of Plasma Exosome-Derived microRNAs and Target Gene Analysis with a Microarray Database of Thermally Injured Skins: Identification of Blood-to-Tissue Interactions at Early Burn Stage.

Authors:  Shi-Ji Li; Zhi-Wen Cai; Hong-Fu Yang; Xu-Dong Tang; Xiao Fang; Le Qiu; Fei Wang; Xu-Lin Chen
Journal:  J Inflamm Res       Date:  2021-12-10

9.  MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1.

Authors:  Shu Wang; Hongmei Sun; Xiaokai Zhan; Qiwen Wang
Journal:  Int J Mol Med       Date:  2019-11-04       Impact factor: 4.101

10.  MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).

Authors:  Xiang Geng; YangYang Sun; JinJin Fu; Liang Cao; Yuan Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.